And the Winner for the Worst Corporate Deal Is Bayer

And the Winner for the Worst Corporate Deal Is Bayer

von | Okt. 27, 2019 | Bayer

Some credit Bayer AG (XTER: BAYN) with making the worst corporate deal in recent memory. With a market cap of about $62 billion, the German conglomerate’s value is below what it paid for Monsanto last year. Even Houdini would have a difficult time making the...
Roche Annual General Meeting 2019

Roche Annual General Meeting 2019

von | Okt. 27, 2019 | Roche

Media Release Basel, 05 March 2019 Roche Annual General Meeting 2019 All proposals of the Board of Directors approved Christoph Franz as Chairman of the Roche Board of Directors and all other Board members standing for re-election approved; Professor Dr Hans Clevers...
Brinks Co (BCO) Holder Brahman Capital Has Decreased Its Holding as Market Valuation Rose; Glaxosmithkline Plc Adr (Gb) (GSK) Shares Rose While Bowen Hanes & Co Has Raised Position by $2.71 Million

Brinks Co (BCO) Holder Brahman Capital Has Decreased Its Holding as Market Valuation Rose; Glaxosmithkline Plc Adr (Gb) (GSK) Shares Rose While Bowen Hanes & Co Has Raised Position by $2.71 Million

von | Okt. 27, 2019 | Glaxo

Bowen Hanes & Co Inc increased its stake in Glaxosmithkline Plc Adr (Gb) (GSK) by 9.6% based on its latest 2019Q2 regulatory filing with the SEC. Bowen Hanes & Co Inc bought 67,675 shares as the company’s stock rose 2.15% . The institutional investor held...